Description
The DSO market isn’t what it was just a few years ago. 2024 saw fewer dental transactions than expected, leaving many wondering what’s next for the industry. Was it interest rates? Overvaluation? Private equity firms tightening their grip? The reality is that DSOs are at a turning point. Some are struggling, while others—especially doctor-led groups—are thriving. The question now is: what does 2025 hold?
In this episode, we talk with Brendan Messenheimer and Samantha Strain from HealthStream Ventures, a firm specializing in dental group investments and M&A. They break down the real reasons behind the slowdown, why some DSOs are failing, and how private equity is shifting its approach. They also reveal the key strategies that will define the next wave of success, including M&A diligence, operational discipline, and how emerging doctor-led DSOs can scale profitably without making the same mistakes as the past.
If you’re in the DSO space—or thinking about entering it—this episode is a must-listen. You’ll learn why the landscape is shifting, which groups are positioned to win, and how to protect your business in an industry that’s evolving fast.
Chapters:
(0:00) Why DSO deals slowed
(15:42) Overvaluation & PE mistakes
(25:31) Doctor-led DSOs rising
(36:48) Future of DSO growth
(47:12) Smarter M&A strategies
Together, we'll reshape the future of dentistry. Visit www.RevolutionDentistryGroup.com to claim the success you actually deserve.
Listen to The Revolution Dentistry Podcast on your favorite podcast platform
Follow The Revolution Dentistry Podcast on Instagram
Leave a review on Apple Podcasts
email us: info@revolutiondentistrygroup.com
Hosted on Ausha. See ausha.co/privacy-policy for more information.